Telmisartan Better antihypertensive Protecting renal

Protection of cardiovascular and cerebral vessels:

Telmisartan stands out as the only sartan-like drug approved by the FDA for its cardiovascular and cerebrovascular protective properties. It demonstrates the ability to reverse left ventricular hypertrophy and is recommended for patients with hypertension accompanied by left ventricular hypertrophy, cardiac insufficiency, or coronary artery disease. In addition to its blood pressure-lowering effects, Telmisartan reduces cardiovascular and cerebrovascular damage. It is particularly beneficial for individuals who have experienced a stroke or cardiac infarction.

Protecting renal function:

Another advantage of Telmisartan is its favorable impact on renal function. Since Telmisartan undergoes hepatic metabolism and is excreted in bile, it has minimal impact on renal function. Moreover, Telmisartan has been found to reduce proteinuria, thereby safeguarding renal function. It is particularly useful in patients with hypertension and comorbid conditions such as diabetic nephropathy, microalbuminuria, proteinuria, or mild to moderate renal insufficiency.

Improvement of insulin resistance:

Telmisartan has demonstrated positive effects on glucose metabolism and insulin resistance. This characteristic makes it a suitable option for patients with hypertension and diabetes mellitus, as it can help improve insulin sensitivity and glucose control.